Tag: RADIATE-VT

Varian Announces First Participant Treated in RADIATE-VT Clinical Trial of Cardiac Radioablation for Patients with Refractory Ventricular Tachycardia

Coronary/Structural Heart by 0 comments

Cardiac RADIoablation versus repeat catheter Ablation: a pivotal randomized clinical Trial Evaluating safety and efficacy for patients with high-risk refractory Ventricular Tachycardia (RADIATE-VT) PALO ALTO, Calif., May 19, 2023 /PRNewswire/ — Varian, a Siemens Healthineers company, announced today that the first participant has been treated in the RADIATE-VT™ […]

Continue Reading →

Varian Receives Investigational Device Exemption for Cardiac Radioablation Clinical Trial, RADIATE-VT

Radiology by 0 comments

Trial Represents an Opportunity to Evaluate a Non-Invasive Treatment Option for Patients with High-Risk Refractory Ventricular Tachycardia PALO ALTO, Calif., Jan. 19, 2023 /PRNewswire/ — Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) approved an Investigational […]

Continue Reading →